Skip to main content
NCBI home page
BioMed Research International logoLink to BioMed Research International
. 2018 Jul 29;2018:7469714. doi: 10.1155/2018/7469714

APLP2 Modulates JNK-Dependent Cell Migration in Drosophila

Xingjun Wang 1,2,✉, Xiaowei Guo 1, Yeqing Ma 1, Chenxi Wu 3, Wenzhe Li 1, Lei Xue 1,✉
PMCID: PMC6093063  PMID: 30155482

Abstract

Amyloid precursor-like protein 2 (APLP2) belongs to the APP family and is widely expressed in human cells. Though previous studies have suggested a role of APLP2 in cancer progression, the exact role of APLP2 in cell migration remains elusive. Here in this report, we show that ectopic expression of APLP2 in Drosophila induces cell migration which is mediated by JNK signaling, as loss of JNK suppresses while gain of JNK enhances such phenotype. APLP2 is able to activate JNK signaling by phosphorylation of JNK, which triggers the expression of matrix metalloproteinase MMP1 required for basement membranes degradation to promote cell migration. The data presented here unraveled an in vivo role of APLP2 in JNK-mediated cell migration.

1. Introduction

Amyloid precursor-like protein-2 (APLP2) belongs to the protein family that includes amyloid precursor protein (APP) and amyloid precursor-like protein-1 (APLP1) in mammals [1, 2]. The three proteins show sequence similarity in the extracellular E1, E2 and the intracellular domains, while only APP and APLP2 share a special Kunitz protease inhibitor (KPI) domain and an Asp-Glu-rich domain, suggesting a role that is likely specific for the two proteins [3, 4]. Consistent with this notion, APP and APLP2 are widely expressed in many tissues, whereas APLP1 is predominantly restricted to the neural cells [5–7]. Studies in knockout mice have unraveled that all the single knockout and the APP/APLP1 double knockout mice are viable and fertile displaying no evident phenotype, while the double knockout mice of APP/APLP2 or APLP1/APLP2 are prenatally lethal, implying a specific role of APLP2 in animal development [8–10], which is consistent with their divergent protein interaction networks observed in an in vivo brain study [11]. Furthermore, the phylogenetic tree of APP protein family indicates that APLP2 is more distant from an inferred ancestral gene than APP and APLP1 [12], suggesting APLP2 may perform distinct in vivo functions.

APLP2 has been shown to regulate multiple cellular functions such as neurite outgrowth, axogenesis, corneal epithelial wound healing, cell adhesion, migration [13], and mitosis [14–17]. The expression level of APLP2 is upregulated in the pancreatic tumor cell lines S2-013, the prostate cancer cell line DU145, and certain human cancers such as breast cancer [18–20] but is downregulated in the lymphoma cell lines [21] and in the lung neuroendocrine tumors [22]. Thus, the exact role of APLP2 in tumorigenesis remains elusive.

The c-Jun N-terminal Kinase (JNK) pathway is a highly conserved signaling from Drosophila to human that governs diverse cellular functions including cell proliferation, differentiation, death, and migration and regulates physiological processes such as stress response and lifespan [23–28]. However, an in vivo role of APLP2 in modulating JNK signaling has not been characterized.

In this work, we studied the in vivo function of human APLP2 in Drosophila. We found that ectopic expression of APLP2 in the wing disc of 3rd instar larvae promotes cell migration, which is suppressed by loss of JNK signaling while exacerbated by gain of JNK signaling. Consistently, APLP2 activates JNK signaling by the phosphorylation of JNK and thus elevates JNK target gene MMP1 expression to initiate cell migration. This work, therefore, provides the first in vivo function of APLP2 in JNK-mediated cell migration.

2. Materials and Methods

2.1. Fly Stocks

All the fly stocks were raised on standard Drosophila corn media and crosses were performed at 25°C unless otherwise indicated. UAS-APLP2 was kindly provided by Dr. Merders; pucH246, UAS-puc-IR, UAS-mmp1-IR, and UAS-p35 were obtained from Bloomington Stock Center; UAS-BskDN, UAS-puc[26], ptc-Gal4, en-Gal4, pucE69[29], and UAS-LacZ [30] were previously described.

2.2. Statistical Analysis for Cell Migration

More than 20 wing discs were dissected for each genotype. The number of migrating cells in the posterior compartment of the wing discs was counted. Unpaired t test by GraphPad Prism 5 was used to analyze the statistical significance. Error bars mean ± SEM, ∗∗∗: p<0.001, ∗∗: p<0.01, and n.s.: no significant difference.

2.3. X-Gal Staining

3rd instar larvae wing discs were dissected in PBST and stained for β galactosidase activity[31]. The steps are shown below: dissect the 3rd instar larvae in buffer A (50mL PBST +50ul 1mM MgCl2 +1.5mL 5M NaCl) (PBST +150mMNaCl+1mM MgCl2); fix the tissue in buffer A containing 1% glutaraldehyde for 15 minutes at 4°C; rinse the tissue once in buffer A containing 3.3 mM K3Fe(CN)6 and 3.3 mM K4Fe(CN)6.3H2O; incubate the tissue in buffer A containing 3.3 mM K3Fe(CN)6 and 3.3 mM K4Fe(CN)6.3H2O. and 0.2%5-bromo-4-chloro-3indolyl-β-D-galactopyranoside (X-gal) at RT 1-4h; and store the tissues in 100% glycerol at 4°C.

2.4. Immunohistochemistry

Antibody staining of the imaginal discs was performed as previously described [32]. Antibodies used are as follows: mouse anti-β-gal (1:400, Developmental Studies Hybridoma Bank), mouse anti-MMP1 (1:100, Developmental Studies Hybridoma Bank), and rabbit anti-phospho-JNK (1:200, Calbiochem). Secondary antibodies were anti-rabbit-Alexa (1:1000, Cell Signaling and Technology) and anti-mouse-Cy3 (1:1000, Jackson ImmunoResearch).

3. Results and Discussion

3.1. APLP2 Promotes Cell Migration in Drosophila

The expression level of APLP2 is increased in many tumor cells suggesting that APLP2 may play a vital role in tumor formation and metastasis[13, 33, 34]. To examine the exact function of APLP2 in cell migration in vivo, we ectopically expressed APLP2 along the anterior/posterior (A/P) compartment boundary in 3rd instar larval wing discs, which has been commonly used to investigate the migrating phenotype in vivo [35]. We noticed that patched-Gal4 (Figures 1(A)–1(A”)) driven expression of APLP2 in the wing disc produced a dosage-dependent invasive phenotype with GFP-labelled cells diverted from the A/P boundary to the posterior part (Figures 1(B)–1(B”), 1(E), Figure S1), while expression of LacZ failed to induce such phenotypes (Figures 1(D)–1(D”), and 1(E)). The c-Jun N-Terminal Protein Kinase (JNK) signaling has been implicated in a wide range of cellular functions including cell death and migration [32, 36–40]. Consistently, RNAi-mediated depletion of puckered (puc), a negative regulator of JNK signaling [41, 42], promoted a cell migrating phenotype (Figures 1(C)–1(C”), and 1(E)). These data indicate that APLP2 is able to trigger cell migration in vivo, which phenocopies that of JNK activation.

Figure 1.

Figure 1

Open in a new tab

APLP2 promotes cell migration in Drosophila. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A–A”), expression of APLP2 induced mild cell migration behavior (B–B”). Activation of JNK signaling by depleting puc also triggered cell migration and served as a positive control (C–C”), while expression of LacZ served as a negative control (D–D”). A'–D' and A”–D” are high magnifications of A–D. (E) Quantification of the cell migration phenotypes, which were classified into four categories based on the number of GFP-labelled cells migrated to the posterior compartment. None: no migrated cells; Weak: 1-5 cells; Moderate: 6-20 cells; Strong: >20 cells. More than 20 discs were examined for each genotype. The crosses were performed at 29°C. ∗∗∗, P<0.001; n.s., no significance. Scale bars in A, A', and A” represent 200 μm, 100 μm, and 50 μm, respectively. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A–A”), ptc-Gal4 UAS-GFP/UAS-APLP2 (B–B”), ptc-Gal4 UAS-GFP/UAS-puc-IR (C–C”), and ptc-Gal4 UAS-GFP/+; UAS-LacZ/+ (D–D”).

3.2. JNK is Required for APLP2-Induced Cell Migration

Since expression of APLP2 induced a migrating phenotype mimicking JNK activation in the wing disc, we hypothesized that JNK signaling pathway might be required for APLP2-triggered cell migration. To test this, we first elevated JNK signaling by deleting one copy of the endogenous puc gene encoding a JNK phosphatase that negatively regulates JNK activity [41, 42]. Compared with the ptc-Gal4 control (Figures 2(A) and 2(I)), we observed that APLP2-induced cell migration phenotype (Figures 2(B) and 2(I)) was dramatically enhanced in heterozygous pucE69 (Figures 2(C) and 2(I)) or pucH246 (Figure S2) mutants, while neither mutant alone could produce any migration phenotype [43], suggesting a genetic interaction between APLP2 and the JNK signaling in promoting cell migration. To further probe the role of JNK signaling in APLP2-induced cell migration, we blocked JNK pathway by expressing a dominant negative form of Drosophila JNK, Bsk [44], or the JNK phosphatase puc. We found that APLP2-induced cell migration was significantly suppressed by the expression of BskDN or puc but remained unaffected by the expression of LacZ (Figures 2(D)–2(F), and 2(I)). Furthermore, blocking JNK signaling also inhibited APLP2-induced, pucE69-enhanced cell migration phenotype (Figures 2(G), 2(H), and 2(I)). Thus, we conclude that APLP2 induces JNK-dependent cell migration in vivo.

Figure 2.

Figure 2

Open in a new tab

APLP2 induces JNK-dependent cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was exacerbated in heterozygous puc mutants (C) and suppressed by the expression of BskDN (D) or puc (E) but remained unaffected by LacZ expression (F). The puc mutant-enhanced APLP2 cell migration phenotype was suppressed by the expression of BskDN (G) or puc (H). (I) Quantification of the migration phenotypes in A–H. The crosses were performed at 29°C. ∗∗∗, P <0.001. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), ptc-Gal4 UAS-GFP/UAS-APLP2; pucE69/+ (C), ptc-Gal4 UAS-GFP/UAS-APLP2; UAS-BskDN/+ (D), ptc-Gal4 UAS-GFP/UAS-APLP2; UAS-puc/+ (E), ptc-Gal4 UAS-GFP/UAS-APLP2; UAS-LacZ/+ (F), ptc-Gal4 UAS-GFP/UAS-APLP2; pucE69/ UAS-BskDN (G), ptc-Gal4 UAS-GFP/UAS-APLP2; pucE69/ UAS-puc (H).

3.3. APLP2 Triggers JNK Activation In Vivo

The above data suggest that APLP2 promotes JNK-mediated cell migration in vivo. To investigate whether APLP2 is able to activate JNK signaling, we checked the expression of a puc-LacZ reporter, a commonly used readout of JNK signaling[27], and JNK phosphorylation in the wing disc. We found that APLP2 was sufficient to induce puc-LacZ expression (Figures 3(B)–3(B”), Figure S3B) and JNK phosphorylation (Figures 3(F)–3(F”)) in wing discs, compared with the ptc-Gal4 control (Figures 3(A)–3(A”), 3(E)–3(E”)). Consistent with the cell migration data, APLP2-induced puc-LacZ expression and JNK phosphorylation was considerably impeded by the expression of BskDN (Figures 3(C)–3(C”), 3(G)–3(G”), Figure S3C) or puc (Figures 3(D)–3(D”), 3(H)–3(H”)). Collectively, the data suggest that APLP2 expression is sufficient to trigger JNK activation in the wing disc.

Figure 3.

Figure 3

Open in a new tab

APLP2 triggers JNK signaling activation. Fluorescence micrographs of wing disc are shown. Compared with the ptc-Gal4 UAS-GFP control (A–A”, E–E”), ectopic expression of APLP2 activated puc-LacZ expression (B–B”) and JNK phosphorylation (F–F”), which were impeded by the expression of BskDN (C–C”, G–G”) or puc (D–D”, H–H”). The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A–A”, E–E”), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B–B”, F–F”), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C–C”, G–G”), ptc-Gal4 UAS-GFP/ UAS-APLP2; puc-LacZ/UAS-puc (D–D”, H–H”).

To investigate whether APLP2 could induce JNK activation in other tissues, we checked the salivary glands where ptc-Gal4 is also expressed. Compared to the control (Figure S4A), expression of APLP2 induced JNK signaling activation, as revealed by the puc-LacZ expression in the gland (Figures S4B). Expression of BskDN fully suppressed both the endogenous and the ectopically activated expression of puc-LacZ (Figure S4C). Together, the data demonstrate that APLP2 is able to activate JNK signaling in a nontissue specific manner.

3.4. APLP2 Induces JNK-Mediated MMP1 Expression

JNK-dependent cell migration is mediated by transcriptional upregulation of the matrix metalloproteinase MMP1[45, 46], which is required for the degradation of basement membrane and serves as a hall marker for cell migration behaviors in Drosophila [47–50]. Consistently, expression of APLP2 driven by ptc-Gal4 induced MMP1 expression in the wing disc (Figures 4(B)–4(B”)), which was dramatically suppressed by the expression of BskDN (Figures 4(C)–4(C”)) or puc (Figures 4(D)–4(D”)). Intriguingly, APLP2 induced both autonomous and nonautonomous JNK phosphorylation (Figures 3(F”)) and MMP1 expression (Figures 4(B”)), which have been previously reported for other migration-promoting genes [37, 38]. Hence, APLP2 is able to induce JNK-mediated MMP1 activation, which is necessary for basement membrane degradation and cell migration. Similar results were observed in the P-compartment of wing discs when APLP2 expression was initiated by engrailed-Gal4 (en-Gal4) (Figure S5). Finally, we examined the role of MMP1 in APLP2-induced cell migration. We found that RNAi-mediated MMP1 depletion impeded APLP2-induced cell migration (Figure S6). Thus, ectopic expression of APLP2 is able to induce JNK-mediated MMP1 upregulation, which is crucial for basement membrane degradation and cell migration. Actin accumulation is a key hint for the cell migration phenotype [45, 46], and APLP2 was shown to modulate actin cytoskeleton in pancreatic cancer cells [13, 33, 34]. Consistently, we found that APLP2 expression could induce actin polymerization in the wing disc (Figure S7).

Figure 4.

Figure 4

Open in a new tab

APLP2 induces JNK-mediated MMP1 expression. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A–A”), ectopic expression of APLP2 activated MMP1 expression (B–B”), which was blocked by expressing BskDN (C–C”) or puc (D–D”). The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A–A”), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B–B”), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C–C”), ptc-Gal4 UAS-GFP/ UAS-APLP2; puc-LacZ/UAS-puc (D–D”).

APLP2 expression is elevated in certain pancreatic and prostate cancer cells as well as in breast cancer samples, while downregulated in lymphoma cells and lung neuroendocrine tumors, implying a controversial role in tumor progression [13, 33, 34]. In this study, we investigated the in vivo function of APLP2 in Drosophila wing disc epithelia. Our data indicate that APLP2 is able to promote JNK-dependent cell migration in vivo. Mechanistically, APLP2 activates JNK signaling through the phosphorylation of JNK, which upregulates the expression of MMP1 that is essential for basement membranes degradation and cell migration. Our previous work showed that expression of APLP2 could induce the expression of apoptotic gene hid and apoptosis[51], yet APLP2-induced cell migration was not blocked by the expression of baculovirus p35 (Figure S8), indicating APLP2-induced cell migration is independent of apoptosis. Consistent with our in vivo results, Chinese hamster ovary (CHO) cells overexpressing APLP2 exhibit increased chemotaxis toward type IV collagen and fibronectin [16], whereas depletion of APLP2 in pancreatic cancer cells resulted in reduced migration and invasion ability [13, 33, 34]. Intriguingly, comparable expression of APLP1[52] triggers stronger cell migration than APLP2 in Drosophila[43], suggesting both amyloid precursor-like proteins can promote cell migration in vivo, albeit at different efficiencies. Consistent with our finding, APLP1 and APLP2 are found to be increased in cancers [13, 33, 34] and knock-down of APLP2 in pancreatic cancer cells reduced the ability of cell migration[13].Yet it remains to be elucidated whether JNK signaling plays a crucial role in APLP2-induced cell migration and tumor invasion in mammals.

Acknowledgments

The authors thank Dr. Gunter Merdes and the Bloomington Stock Center for providing fly stocks. This research is supported by the Fundamental Research Funds for the Central Universities to Xingjun Wang (2000219125) and Wenzhe Li (2000219142), the National Natural Science Foundation of China (31701244), Natural Science Fund of Hebei Province of China (C2018209119), Scientific and Technological Research Project of Higher Education of Hebei Province (QN2017118), and Doctoral Scientific Research Foundation of North China University of Science and Technology (BS2017063) to Chenxi Wu.

Contributor Information

Xingjun Wang, Email: 2011wxj_fly_ing@tongji.edu.cn.

Lei Xue, Email: lei.xue@tongji.edu.cn.

Data Availability

No data were used to support this study.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

Xingjun Wang and Lei Xue conceived the project. Xingjun Wang, Xiaowei Guo, Yeqing Ma, Chenxi Wu, and Wenzhe Li performed the experiments. Xingjun Wang and Lei Xue wrote the manuscript. Xingjun Wang and Xiaowei Guo contributed equally to this work.

Supplementary Materials

Supplementary 1

Figure S1: APLP2 induced dosage-dependent cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was enhanced by adding another copy of APLP2 (C). (D) Quantification of migration phenotype in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP UAS-APLP2 /UAS-APLP2 (C).

Click here for additional data file. (257.1KB, docx)
Supplementary 2

Figure S2: loss of puc enhances APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was aggravated in heterozygous pucH246 mutants (C). (D) Quantification of migration phenotype in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; pucH246/+ (C).

Click here for additional data file. (269.6KB, docx)
Supplementary 3

Figure S3: APLP2 activates JNK signaling in the wing disc. Light micrographs of wing discs are shown. The expression pattern of ptc-Gal4 was indicated by the red dashing line. Compared with the control (A), expression of APLP2 induced puc-LacZ expression in the wing pouch (B), which was blocked by expressing BskDN (C). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C).

Click here for additional data file. (437.9KB, docx)
Supplementary 4

Figure S4: APLP2 activates JNK signaling in the salivary gland. Light micrographs of salivary glands are shown. Compared with the control (A), expression of APLP2 induced puc-LacZ expression in the salivary gland (B), which was blocked by expressing BskDN (C). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C).

Click here for additional data file. (173.4KB, docx)
Supplementary 5

Figure S5: APLP2 induces JNK-mediated MMP1 expression in the wing disc. Fluorescence micrographs of wing discs are shown. Compared with the en-Gal4 UAS-GFP control (A–A”), ectopic expression of APLP2 in the posterior compartment of wing disc elevated MMP1 expression (B–B”), which was blocked by expressing BskDN (C–C”). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: en-Gal4 UAS-GFP/+; (A), en-Gal4 UAS-GFP/UAS-APLP2 (B), and en-Gal4 UAS-GFP/UAS-APLP2; UAS-BskDN/+(C).

Click here for additional data file. (1.5MB, docx)
Supplementary 6

Figure S6: depletion of MMP1 compromises APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was compromised by RNAi-mediated depletion of mmp1 (C). (D) Quantification of the migration phenotypes in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001, ∗∗, P <0.01. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; UAS-mmp1-IR/+ (C).

Click here for additional data file. (203.7KB, docx)
Supplementary 7

Figure S7: APLP2 induces actin polymerization. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A–A”'), APLP2 induces cell migration and actin remodeling (B–B”'). The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A–A”'), and ptc-Gal4 UAS-GFP/UAS-APLP2; pucE69/+ (B–B”').

Click here for additional data file. (569KB, docx)
Supplementary 8

Figure S8: expression of p35 fails to block APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) cannot be blocked by expression of p35 (C). The white arrow in B and C indicates the GFP-labelled migrating cells. The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; p35/+ (C).

Click here for additional data file. (498.7KB, docx)

References

  • 1.Zheng H., Koo E. H. The amyloid precursor protein: beyond amyloid. Molecular Neurodegeneration. 2006;1:p. 5. doi: 10.1186/1750-1326-1-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bush A. I., et al. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. Journal of Biological Chemistry. 1994;269(43):26618–26621. [PubMed] [Google Scholar]
  • 3.Dyrks T., et al. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. The EMBO Journal. 1988;7(4):949–957. doi: 10.1002/j.1460-2075.1988.tb02900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sandbrink R., Masters C. L., Beyreuther K. Similar alternative splicing of a non-homologous domain in βA4-amyloid protein precursor-like proteins. The Journal of Biological Chemistry. 1994;269(19):14227–14234. [PubMed] [Google Scholar]
  • 5.Sprecher C. A., Grant F. J., Grimm G., et al. Molecular Cloning of the cDNA for a Human Amyloid Precursor Protein Homolog: Evidence for a Multigene Family. Biochemistry. 1993;32(17):4481–4486. doi: 10.1021/bi00068a002. [DOI] [PubMed] [Google Scholar]
  • 6.Wasco W., Gurubhagavatula S., Paradis M. d., et al. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genetics. 1993;5(1):95–100. doi: 10.1038/ng0993-95. [DOI] [PubMed] [Google Scholar]
  • 7.McNamara M. J., Ruff C. T., Wasco W., Tanzi R. E., Thinakaran G., Hyman B. T. Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains. Brain Research. 1998;804(1):45–51. doi: 10.1016/S0006-8993(98)00653-2. [DOI] [PubMed] [Google Scholar]
  • 8.Heber S., Herms J., Gajic V., et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. The Journal of Neuroscience. 2000;20(21):7951–7963. doi: 10.1523/JNEUROSCI.20-21-07951.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Von Koch C. S., Zheng H., Chen H., et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiology of Aging. 1997;18(6):661–669. doi: 10.1016/s0197-4580(97)00151-6. [DOI] [PubMed] [Google Scholar]
  • 10.Zheng H., et al. Beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995;81(4):525–531. doi: 10.1016/0092-8674(95)90073-x. [DOI] [PubMed] [Google Scholar]
  • 11.Bai Y., Markham K., Chen F., et al. The in vivo brain interactome of the amyloid precursor protein. Molecular & Cellular Proteomics. 2008;7(1):15–34. doi: 10.1074/mcp.M700077-MCP200. [DOI] [PubMed] [Google Scholar]
  • 12.Shariati S. A. M., De Strooper B. Redundancy and divergence in the amyloid precursor protein family. FEBS Letters. 2013;587(13):2036–2045. doi: 10.1016/j.febslet.2013.05.026. [DOI] [PubMed] [Google Scholar]
  • 13.Pandey P., Sliker B., Peters H. L., et al. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget . 2016;7(15):19430–19444. doi: 10.18632/oncotarget.7103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cappai R., Mok S. S., Galatis D., et al. Recombinant human amyloid precursor-like protein 2 (APLP2) expressed in the yeast Pichia pastoris can stimulate neurite outgrowth. FEBS Letters. 1999;442(1):95–98. doi: 10.1016/S0014-5793(98)01635-4. [DOI] [PubMed] [Google Scholar]
  • 15.Guo J., et al. A role for amyloid precursor-like protein 2 in corneal epithelial wound healing. Investigative Ophthalmology & Visual Science. 1998;39(2):292–300. [PubMed] [Google Scholar]
  • 16.Li X.-F., Thinakaran G., Sisodia S. S., Yu F.-S. X. Amyloid precursor-like protein 2 promotes cell migration toward fibronectin and collagen IV. The Journal of Biological Chemistry. 1999;274(38):27249–27256. doi: 10.1074/jbc.274.38.27249. [DOI] [PubMed] [Google Scholar]
  • 17.Thinakaran G., Kitt C. A., Roskams A. J. I., et al. Distribution of an APP homolog, APLP2, in the mouse olfactory system: A potential role for APLP2 in axogenesis. The Journal of Neuroscience. 1995;15(10):6314–6326. doi: 10.1523/JNEUROSCI.15-10-06314.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Covell D. G., et al. Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data. Molecular Cancer Therapeutics. 2003;2(3):317–332. [PubMed] [Google Scholar]
  • 19.Abba M. C., Drake J. A., Hawkins K. A., et al. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Research. 2004;6(5):R499–R513. doi: 10.1186/bcr899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Peters H. L., Tuli A., Sharma M., et al. Regulation of major histocompatibility complex class i molecule expression on cancer cells by amyloid precursor-like protein 2. Immunologic Research. 2011;51(1):39–44. doi: 10.1007/s12026-011-8238-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tuli A., Sharma M., Wang X., et al. Amyloid precursor-like protein 2 association with HLA class i molecules. Cancer Immunology, Immunotherapy. 2009;58(9):1419–1431. doi: 10.1007/s00262-009-0657-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Arvidsson Y., Andersson E., Bergström A., et al. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract. Endocrine-Related Cancer. 2008;15(2):569–581. doi: 10.1677/ERC-07-0145. [DOI] [PubMed] [Google Scholar]
  • 23.Bacher S., Großhans J., Dröge W., Schmitz M. L. The Drosophila proteins Pelle and Tube induce JNK/AP-1 activity in mammalian cells. FEBS Letters. 2001;497(2-3):153–158. doi: 10.1016/S0014-5793(01)02454-1. [DOI] [PubMed] [Google Scholar]
  • 24.Igaki T., Kanda H., Yamamoto-Goto Y., et al. Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO Journal. 2002;21(12):3009–3018. doi: 10.1093/emboj/cdf306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Biteau B., Karpac J., Hwangbo D., Jasper H. Regulation of Drosophila lifespan by JNK signaling. Experimental Gerontology. 2011;46(5):349–354. doi: 10.1016/j.exger.2010.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ma X., Huang J., Yang L., Yang Y., Li W., Xue L. NOPO modulates Egr-induced JNK-independent cell death in Drosophila. Cell Research. 2012;22(2):425–431. doi: 10.1038/cr.2011.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Xue L., Igaki T., Kuranaga E., Kanda H., Miura M., Xu T. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila. Developmental Cell. 2007;13(3):446–454. doi: 10.1016/j.devcel.2007.07.012. [DOI] [PubMed] [Google Scholar]
  • 28.Huang Jiuhong, Xue Lei. Loss of flfl Triggers JNK-Dependent Cell Death in Drosophila. BioMed Research International. 2015;2015:1–8. doi: 10.1155/2015/623573.623573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ma X., Shao Y., Zheng H., Li M., Li W., Xue L. Src42A modulates tumor invasion and cell death via Ben/dUev1a-mediated JNK activation in Drosophila. Cell Death & Disease. 2013;4(10, article e864) doi: 10.1038/cddis.2013.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Li W.-Z., Li S.-L., Zheng H. Y., Zhang S.-P., Xue L. A broad expression profile of the GMR-GAL4 driver in Drosophila melanogaster. Genetics and Molecular Research. 2012;11(3):1997–2002. doi: 10.4238/2012.August.6.4. [DOI] [PubMed] [Google Scholar]
  • 31.Xue L., Noll M. Dual role of the Pax gene paired in accessory gland development of Drosophila. Development. 2002;129(2):339–346. doi: 10.1242/dev.129.2.339. [DOI] [PubMed] [Google Scholar]
  • 32.Igaki T., Pagliarini R. A., Xu T. Loss of Cell Polarity Drives Tumor Growth and Invasion through JNK Activation in Drosophila. Current Biology. 2006;16(11):1139–1146. doi: 10.1016/j.cub.2006.04.042. [DOI] [PubMed] [Google Scholar]
  • 33.Pandey P., Rachagani S., Das S., et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget . 2015;6(4):2064–2075. doi: 10.18632/oncotarget.2990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Peters H. L., Tuli A., Wang X., et al. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. International Journal of Oncology. 2012;41(4):1464–1474. doi: 10.3892/ijo.2012.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Vidal M., Larson D. E., Cagan R. L. Csk-deficient boundary cells are eliminated from normal drosophila epithelia by exclusion, migration, and apoptosis. Developmental Cell. 2006;10(1):33–44. doi: 10.1016/j.devcel.2005.11.007. [DOI] [PubMed] [Google Scholar]
  • 36.Huang C., Jacobson K., Schaller M. D. A role for JNK-paxillin signaling in cell migration. Cell Cycle. 2004;3(1):4–6. [PubMed] [Google Scholar]
  • 37.Ma X., Wang H., Ji J., et al. Hippo signaling promotes JNK-dependent cell migration. Proceedings of the National Acadamy of Sciences of the United States of America. 2017;114(8):1934–1939. doi: 10.1073/pnas.1621359114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ma X., Huang J., Tian Y., et al. Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling. Oncogene. 2017;36(22):3159–3167. doi: 10.1038/onc.2016.463. [DOI] [PubMed] [Google Scholar]
  • 39.Huang Z., Yan D.-P., Ge B.-X. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin. Cellular Signalling. 2008;20(11):2002–2012. doi: 10.1016/j.cellsig.2008.07.014. [DOI] [PubMed] [Google Scholar]
  • 40.Zhang T., Sheng Z., Du W. Loss of histone deacetylase HDAC1 induces cell death in Drosophila epithelial cells through JNK and Hippo signaling. Mechanisms of Development. 2016;141:4–13. doi: 10.1016/j.mod.2016.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Martín-Blanco E., Gampel A., Ring J., et al. Puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes & Development. 1998;12(4):557–670. doi: 10.1101/gad.12.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wu C., Chen C., Dai J., et al. Toll pathway modulates TNF-induced JNK-dependent cell death in Drosophila. Open Biology. 2015;5, article 140171(7) doi: 10.1098/rsob.140171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wang X., Sun Y., Han S., et al. Amyloid precursor like protein-1 promotes JNK-mediated cell migration in Drosophila. Oncotarget . 2017;8(30):49725–49734. doi: 10.18632/oncotarget.17681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sluss H. K., Han Z., Barrett T., Davis R. J., Ip Y. T. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes & Development. 1996;10(21):2745–2758. doi: 10.1101/gad.10.21.2745. [DOI] [PubMed] [Google Scholar]
  • 45.Srivastava A., Pastor-Pareja J. C., Igaki T., Pagliarini R., Xu T. Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion. Proceedings of the National Acadamy of Sciences of the United States of America. 2007;104(8):2721–2726. doi: 10.1073/pnas.0611666104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rudrapatna V. A., Bangi E., Cagan R. L. Caspase signalling in the absence of apoptosis drives Jnk-dependent invasion. EMBO Reports. 2013;14(2):172–177. doi: 10.1038/embor.2012.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pannem R. R., Dorn C., Ahlqvist K., Bosserhoff A. K., Hellerbrand C., Massoumi R. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis. 2014;35(2):461–468. doi: 10.1093/carcin/bgt335. [DOI] [PubMed] [Google Scholar]
  • 48.Beaucher M., Hersperger E., Page-McCaw A., Shearn A. Metastatic ability of Drosophila tumors depends on MMP activity. Developmental Biology. 2007;303(2):625–634. doi: 10.1016/j.ydbio.2006.12.001. [DOI] [PubMed] [Google Scholar]
  • 49.Deryugina E. I., Quigley J. P. Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews. 2006;25(1):9–34. doi: 10.1007/s10555-006-7886-9. [DOI] [PubMed] [Google Scholar]
  • 50.Halbersztadt A., et al. The role of matrix metalloproteinases in tumor invasion and metastasis. Ginekologia Polska. 2006;77(1):63–71. [PubMed] [Google Scholar]
  • 51.Wang X., Ma Y., Zhao Y., et al. APLP1 promotes dFoxO-dependent cell death in Drosophila. Apoptosis. 2015;20(6):778–786. doi: 10.1007/s10495-015-1097-1. [DOI] [PubMed] [Google Scholar]
  • 52.Merdes G., Soba P., Loewer A., Bilic M. V., Beyreuther K., Paro R. Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila. EMBO Journal. 2004;23(20):4082–4095. doi: 10.1038/sj.emboj.7600413. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary 1

Figure S1: APLP2 induced dosage-dependent cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was enhanced by adding another copy of APLP2 (C). (D) Quantification of migration phenotype in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP UAS-APLP2 /UAS-APLP2 (C).

Click here for additional data file. (257.1KB, docx)
Supplementary 2

Figure S2: loss of puc enhances APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was aggravated in heterozygous pucH246 mutants (C). (D) Quantification of migration phenotype in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; pucH246/+ (C).

Click here for additional data file. (269.6KB, docx)
Supplementary 3

Figure S3: APLP2 activates JNK signaling in the wing disc. Light micrographs of wing discs are shown. The expression pattern of ptc-Gal4 was indicated by the red dashing line. Compared with the control (A), expression of APLP2 induced puc-LacZ expression in the wing pouch (B), which was blocked by expressing BskDN (C). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C).

Click here for additional data file. (437.9KB, docx)
Supplementary 4

Figure S4: APLP2 activates JNK signaling in the salivary gland. Light micrographs of salivary glands are shown. Compared with the control (A), expression of APLP2 induced puc-LacZ expression in the salivary gland (B), which was blocked by expressing BskDN (C). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+; puc-LacZ/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/+ (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; puc-LacZ/UAS-BskDN (C).

Click here for additional data file. (173.4KB, docx)
Supplementary 5

Figure S5: APLP2 induces JNK-mediated MMP1 expression in the wing disc. Fluorescence micrographs of wing discs are shown. Compared with the en-Gal4 UAS-GFP control (A–A”), ectopic expression of APLP2 in the posterior compartment of wing disc elevated MMP1 expression (B–B”), which was blocked by expressing BskDN (C–C”). The crosses were performed at 25°C. Scale bar in A represents 200 μm. The genotypes used in the figure are as follows: en-Gal4 UAS-GFP/+; (A), en-Gal4 UAS-GFP/UAS-APLP2 (B), and en-Gal4 UAS-GFP/UAS-APLP2; UAS-BskDN/+(C).

Click here for additional data file. (1.5MB, docx)
Supplementary 6

Figure S6: depletion of MMP1 compromises APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) was compromised by RNAi-mediated depletion of mmp1 (C). (D) Quantification of the migration phenotypes in A–C. The crosses were performed at 29°C. ∗∗∗, P <0.001, ∗∗, P <0.01. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; UAS-mmp1-IR/+ (C).

Click here for additional data file. (203.7KB, docx)
Supplementary 7

Figure S7: APLP2 induces actin polymerization. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A–A”'), APLP2 induces cell migration and actin remodeling (B–B”'). The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A–A”'), and ptc-Gal4 UAS-GFP/UAS-APLP2; pucE69/+ (B–B”').

Click here for additional data file. (569KB, docx)
Supplementary 8

Figure S8: expression of p35 fails to block APLP2-induced cell migration. Fluorescence micrographs of wing discs are shown. Compared with the ptc-Gal4 UAS-GFP control (A), APLP2-induced cell migration (B) cannot be blocked by expression of p35 (C). The white arrow in B and C indicates the GFP-labelled migrating cells. The crosses were performed at 29°C. Scale bar in A represents 100 μm. The genotypes used in the figure are as follows: ptc-Gal4 UAS-GFP/+ (A), ptc-Gal4 UAS-GFP/UAS-APLP2 (B), and ptc-Gal4 UAS-GFP/UAS-APLP2; p35/+ (C).

Click here for additional data file. (498.7KB, docx)

Data Availability Statement

No data were used to support this study.

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES